Tenaya Therapeutics shareholders approve amended 2021 equity incentive plan at annual meeting
Tenaya Therapeutics, Inc. TNYA | 0.00 |
- Tenaya Therapeutics held its annual shareholder meeting on May 27, 2026.
- Shareholders ratified Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
- Investors approved an amended and restated 2021 equity incentive plan, effective May 27, 2026, including a one-time increase of 6,509,966 shares.
- The revised plan also removes the 4 million annual cap on the evergreen increase while keeping the annual increase at 4% of outstanding shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tenaya Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-248680), on May 29, 2026, and is solely responsible for the information contained therein.
